头孢乙腈和头孢尼西在人血清存在下的抗葡萄球菌活性。
Antistaphylococcal activity of ceforanide and cefonicid in the presence of human serum.
作者信息
Barry A L, Jones R N, Packer R R
出版信息
Antimicrob Agents Chemother. 1986 Jan;29(1):147-9. doi: 10.1128/AAC.29.1.147.
Abstract
Tests with 52 strains of Staphylococcus aureus compared ceforanide and cefonicid. Addition of 50% human serum to the test system reduced the bacteriostatic and bactericidal activities of cefonicid, but ceforanide was not affected as greatly.
摘要
对52株金黄色葡萄球菌进行的试验比较了头孢乙腈和头孢尼西。向测试系统中添加50%的人血清会降低头孢尼西的抑菌和杀菌活性，但头孢乙腈受影响程度较小。
相似文献
1
Antistaphylococcal activity of ceforanide and cefonicid in the presence of human serum.头孢乙腈和头孢尼西在人血清存在下的抗葡萄球菌活性。
Antimicrob Agents Chemother. 1986 Jan;29(1):147-9. doi: 10.1128/AAC.29.1.147.
2
A comparison of cefonicid with other beta-lactams regarding the effect of human and mouse sera on antibacterial activity.
Acta Microbiol Hung. 1987;34(1):39-44.
3
Review of the new second-generation cephalosporins: cefonicid, ceforanide, and cefuroxime.新型第二代头孢菌素综述：头孢尼西、头孢雷特和头孢呋辛。
Drug Intell Clin Pharm. 1985 Mar;19(3):188-98. doi: 10.1177/106002808501900304.
4
Ceforanide. A review of its antibacterial activity, pharmacokinetic properties and clinical efficacy.头孢雷特。对其抗菌活性、药代动力学特性及临床疗效的综述。
Drugs. 1987 Oct;34(4):411-37. doi: 10.2165/00003495-198734040-00001.
5
[In-vitro activity of cefonicid on hospital bacteria. Regression line and proposal for critical values].[头孢尼西对医院细菌的体外活性。回归线及临界值建议]
Pathol Biol (Paris). 1986 May;34(5):385-9.
6
Microbiological and pharmacokinetic evaluation of cefonicid, a long-acting cephalosporin.
Chemioterapia. 1987 Jun;6(2 Suppl):243-6.
7
Cefonicid, a long acting cephalosporin: in vitro activity compared with three cephalosporins and gentamicin.
Drugs Exp Clin Res. 1986;12(11):861-9.
8
In vitro experience with cefonicid.
Rev Infect Dis. 1984 Nov-Dec;6 Suppl 4:S783-90. doi: 10.1093/clinids/6.supplement_4.s783.
9
Comparative bactericidal effect of ceforanide (BL-S 786) and five other cephalosporins in an in vitro pharmacokinetic model.头孢雷特（BL-S 786）与其他五种头孢菌素在体外药代动力学模型中的杀菌效果比较
J Antibiot (Tokyo). 1979 Jul;32(7):727-33. doi: 10.7164/antibiotics.32.727.
10
Failure of a once-daily regimen of cefonicid for treatment of endocarditis due to Staphylococcus aureus.每日一次使用头孢尼西治疗金黄色葡萄球菌性心内膜炎失败。
Rev Infect Dis. 1984 Nov-Dec;6 Suppl 4:S870-4. doi: 10.1093/clinids/6.supplement_4.s870.
引用本文的文献
1
Antimicrobial activity of ceftriaxone, cefotaxime, desacetylcefotaxime, and cefotaxime-desacetylcefotaxime in the presence of human serum.头孢曲松、头孢噻肟、去乙酰头孢噻肟及头孢噻肟-去乙酰头孢噻肟在人血清存在下的抗菌活性。
Antimicrob Agents Chemother. 1987 May;31(5):818-20. doi: 10.1128/AAC.31.5.818.
2
Unpredictable influence of human serum on antimicrobial activity of erythromycin and three oxime ether macrolides.
Eur J Clin Microbiol. 1987 Feb;6(1):81-2. doi: 10.1007/BF02097206.
3
Ceforanide. A review of its antibacterial activity, pharmacokinetic properties and clinical efficacy.头孢雷特。对其抗菌活性、药代动力学特性及临床疗效的综述。
Drugs. 1987 Oct;34(4):411-37. doi: 10.2165/00003495-198734040-00001.
4
Effects of supraphysiologic temperature and broth dilution on serum protein binding.超生理温度和肉汤稀释对血清蛋白结合的影响。
Antimicrob Agents Chemother. 1990 Jun;34(6):1257-8. doi: 10.1128/AAC.34.6.1257.
5
Effect of serum on the in vitro activities of 11 broad-spectrum antibiotics.血清对11种广谱抗生素体外活性的影响。
Antimicrob Agents Chemother. 1990 Nov;34(11):2234-9. doi: 10.1128/AAC.34.11.2234.
本文引用的文献
1
Twice-daily intramuscular ceforanide therapy of Staphylococcus aureus endocarditis in parenteral drug abusers.对静脉药物滥用者的金黄色葡萄球菌性心内膜炎采用每日两次肌肉注射头孢乙腈进行治疗。
Antimicrob Agents Chemother. 1984 Jan;25(1):16-9. doi: 10.1128/AAC.25.1.16.
2
Failure of a once-daily regimen of cefonicid for treatment of endocarditis due to Staphylococcus aureus.每日一次使用头孢尼西治疗金黄色葡萄球菌性心内膜炎失败。
Rev Infect Dis. 1984 Nov-Dec;6 Suppl 4:S870-4. doi: 10.1093/clinids/6.supplement_4.s870.
3
Effect of hydrogen ion and protein concentrations on the activity of beta-lactam antibiotics.氢离子和蛋白质浓度对β-内酰胺类抗生素活性的影响
Rev Infect Dis. 1984 Nov-Dec;6 Suppl 4:S829-34. doi: 10.1093/clinids/6.supplement_4.s829.
4
Tissue penetration and half-life of cefonicid.
Rev Infect Dis. 1984 Nov-Dec;6 Suppl 4:S821-8. doi: 10.1093/clinids/6.supplement_4.s821.
5
MBCs for Staphylococcus aureus as determined by macrodilution and microdilution techniques.采用常量稀释法和微量稀释法测定的金黄色葡萄球菌的最低杀菌浓度。
Antimicrob Agents Chemother. 1984 Aug;26(2):214-9. doi: 10.1128/AAC.26.2.214.
6
Cefonicid in a once-daily regimen for treatment of osteomyelitis in an ambulatory setting.
Rev Infect Dis. 1984 Nov-Dec;6 Suppl 4:S865-9. doi: 10.1093/clinids/6.supplement_4.s865.
7
Influence of growth medium on the in vitro activities of second- and third-generation cephalosporins against Streptococcus faecalis.生长培养基对第二代和第三代头孢菌素体外抗粪肠球菌活性的影响。
J Clin Microbiol. 1984 Sep;20(3):561-7. doi: 10.1128/jcm.20.3.561-567.1984.
8
Comparison of cefonicid and cefazolin for treatment of soft-tissue infections.
Rev Infect Dis. 1984 Nov-Dec;6 Suppl 4:S853-6. doi: 10.1093/clinids/6.supplement_4.s853.
9
BL-S786, a new parenteral cephalosporin. II. In vitro antimicrobial activity comparison with six related cephalosporins.BL-S786，一种新型胃肠外给药头孢菌素。II. 与六种相关头孢菌素的体外抗菌活性比较。
J Antibiot (Tokyo). 1977 Jul;30(7):583-92. doi: 10.7164/antibiotics.30.583.
10
Clinical pharmacokinetics and safety of high doses of ceforanide (BL-S786R) and cefazolin.高剂量头孢雷特（BL-S786R）和头孢唑林的临床药代动力学及安全性
Antimicrob Agents Chemother. 1979 Nov;16(5):615-21. doi: 10.1128/AAC.16.5.615.
Zotero 插件